http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5920301-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
filingDate 1982-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8835faba4e60eb92c3d1d92a42e3c8e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_068c515865c4a6a1774ebb65efec5009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80e2fd6e5c573a287a09d521d0149c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b8b8639b87c4bc00ee73073c1824e2e
publicationDate 1984-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5920301-A
titleOfInvention Production of urokinase/dextran derivative
abstract PURPOSE: To obtain the titled derivative in high yields, by gently reducing a specified urokinase/dextran conjugate with a metal cyanoborohydride and further reducing the product with a metal borohydride. n CONSTITUTION: A compound of formula I (wherein P is a dextran residue, and E is a urokinase residue) is reduced gently with sodium cyanoborohydride and then further reduced with sodium borohydride. By this two-stage reduction comprising gentle reduction and subsequent reduction, it is possible to obtain a urokinase/ dextran derivative of formula II in high yields. Here, the compound of formula I can be obtained by reacting dextran with an oxide (e.g., sodium periodate), thereby converting the hydroxyl groups of dextran into aldehyde groups to form activated dextran, and then reacting this activated dextran with urokinase. n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6632939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9919364-A1
priorityDate 1982-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20587905
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00749
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100008445
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18792
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099820
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450059958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05589
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6338343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447816241
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29598
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25619
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5RF29
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16227
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MHY7

Total number of triples: 50.